ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2016

Mar 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2016-03-04

Reporting Person: Myszkowski Kenneth Allen (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-04	Common Stock	F	6263	$4.33	Disposed	115689	Direct

Footnotes

F1: This transaction reflects the payment of the tax liability by withholding securities incident to the vesting of restricted stock units.